Key Takeaways
- • Psychiatrists at the University of Zurich and the Mainau Practice have proposed Family Office Psychiatry, a new clinical framework for treating ultra-high net-worth individuals (UHNWIs), defined as those with investable financial assets above $30 million.
- • The authors cite a population of more than half a million UHNW individuals in 2025, controlling an estimated $59.8 trillion in wealth, as the basis for an underserved clinical market.
- • The model positions a senior psychiatrist as a longitudinal mental health advisor to an entire family, expanding from one patient to spouses, children and key corporate personnel.
- • The framework is based on clinical experience across more than 200 patient cases and is presented as a set of practice-derived hypotheses intended to prompt formal academic and empirical research.
- • The authors flag embedded care, boundary management, multi-member treatment conflicts and cross-border prescribing rules as the main ethical and regulatory challenges.
Summary
The framework borrows its structure from the traditional financial family office. A senior psychiatric clinician acts as a longitudinal mental health advisor to a family and its wider professional ecosystem. Treatment typically begins with one individual and expands over time to spouses, children and key corporate personnel as trust develops. The clinician coordinates a network of specialists, nutritionists, mindfulness practitioners and physical therapists. The paper contrasts this with standard outpatient care, which focuses on the individual and generally discourages treating multiple family members. Family Office Psychiatry instead uses encrypted messaging, telephone access within pre-negotiated contractual limits, international travel and telemedicine, and referrals to curated networks that can include private inpatient facilities.
The authors highlight embedded psychiatric care, in which the clinician accompanies the patient at home, while traveling or in corporate settings. This allows direct observation of family dynamics but increases the risk of role blurring and interpersonal friction, so the authors call for clear contracts, robust supervision and eventual rigorous studies of efficacy. The paper also describes clinical concerns including eroded trust, addiction without the external limits that wealth removes, developmental effects of delegated caregiving, and succession syndrome in intergenerational transfers. It further notes vulnerabilities among young founders who gain sudden wealth from artificial intelligence and fintech. Treating multiple family members requires separate clinicians for close relatives to avoid conflicting loyalties, and cross-border care introduces regulatory and prescribing hurdles. The authors call for systematic empirical research to test the model.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.